Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Oct 30 - Nov 4
Retatrutide redesigns multi-agonism Approval Outlook Neither CagriSema nor Retatrutide should be treated as FDA-approved therapy in 2026 until regulators say otherwise
If you are taking 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, these doses can be administered via a multi-dose pen, this means you dont need to measure your dose, each pen contains 4 doses that will last for 4 weeks
Its suspected many more would use weight-loss injections if they were offered free on public healthcare
IVIM offers unlimited provider access, including optional weekly provider check-ins for dose adjustments or other questions
Reach out to our Orlando center to schedule your evaluation
